Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zopiclone plus oxygen for obstructive sleep apnoea
ACTRN12615000858594Phase 2Not yet recruiting
- Sponsor
- A/Prof Peter Catcheside
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of zopiclone in obstructive sleep apnea hypopnea syndrome (OSAHS), sponsored by A/Prof Peter Catcheside. Primary endpoint: Apnoea-Hypopnoea Index without conventional oxygen desaturation criteria. Planned start Dec 2015; status: not yet recruiting.
02
Drugs
zopiclone
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ACTRN12615000858594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000858594.